Moneycontrol PRO
UPCOMING EVENT: We will crown India’s Sustainability Champions at the first Sustainability100+ Awards tomorrow. Be there!

Market Headstart: Nifty likely to consolidate around 11,700; NIIT Tech, IPCA top buys

Trends on SGX Nifty indicate a negative opening for the broader index in India, with a 94 points loss or 0.8 percent. The Nifty futures were trading around 11,724-level on the Singaporean Exchange.

February 26, 2020 / 09:22 AM IST

Indian market is likely to consolidate around 11,700 levels on February 26 tracking mixed trend seen in other Asian markets.

Asian shares fell on Wednesday after a US government warned Americans to prepare for the possibility of a coronavirus pandemic. This pushed Wall Street stocks lower and yields on safe-haven Treasuries to record lows.

Trends on SGX Nifty indicate a negative opening in India, with a 94 points, or 0.8 percent, loss. The Nifty futures were trading around 11,724-level on the Singaporean Exchange.

Indian markets consolidated and closed in the red for the third consecutive day in a row on Tuesday amid weak global cues. Tracking the weakness, more than 200 stocks hit a fresh 52-week low on the BSE.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

These include Gillette India, Hero MotoCorp, L&T, BASF India, LIC Housing Finance, HPCL, Canara Bank, DCB Bank, among others.

Let’s look at the final tally on D-Street – the S&P BSE Sensex closed 82 points lower at 40,281 while the Nifty50 fell 31 points to close at 11,797.

Sectorally, the action was seen in realty, telecom, IT and metal stocks while profit-taking was witnessed in energy, oil & gas, healthcare, consumer durables, and auto indices.

The rupee on February 25 recovered 13 paise to close at 71.85 (provisional) against the US dollar amid easing crude oil prices and weakening of the American currency in the overseas market.

On the provisional front, FPIs were net sellers in Indian markets for Rs 2315 cr while the DIIs were net buyer to the tune of Rs 1565 cr, provisional data showed.

Big News:

A big trade deal could be in the offing between the US and India: sources

Prime Minister Narendra Modi on Tuesday said increasing the bilateral defence and security cooperation is a very key aspect of this relationship.

Modi said as far as bilateral trade is concerned, there have been positive talks between the two commerce ministers.

India and the US on Tuesday finalised defense deals worth USD 3 billion and signed three MoUs, including one in the energy sector

Technical View:

Nifty formed a bearish candle on the daily charts for the 3rd consecutive day in a row

Bulls have put in a tough fight around 11800 levels| Critical support is placed around 11783 – 11740 levels

There seem to be multiple supports emerging on the downsides at every 50 point decline. In case if Nifty fails to hold 11749 then it can head to test its 200-Days Simple Moving Average (SMA) support placed around 11684 levels

Strength is expected to come if Nifty manages a close above 11900 in the next couple of trading sessions which then can pave the way for sideways consolidation, suggest experts

Traders are advised to remain neutral and focus on stock-specific opportunities.

Three levels: 11779-11750, 11883, 11900

Max Call OI: 12000, 12200

Max Put OI: 11800, 11700

Stocks in the news:

India Cements: Gopikishan S Damani, the brother of ace investor Radhakishan Damani, bought 2.75 percent stake in India Cements on February 25.

Bank of Baroda: BoB said it has moved the Supreme Court against an order passed by the Calcutta High Court in a matter related to a bank guarantee issued on behalf of Simplex Projects Ltd.

Vedanta: Anil Agarwal said he is open to selling a stake in Cairn India to make it valuable for investors. Agarwal said that the company is interested in buying a stake in BPCL.

Technical Recommendations:

We spoke to SMC Global Securities and here’s what they have to recommend:

Minda Corporation Ltd: Buy| LTP: Rs 115.25| Target: Rs 126| Stop Loss: Rs 105| Upside 9%

IPCA Laboratories Ltd: Buy| LTP: Rs 1426| Target: Rs 1584| Stop Loss: Rs 1290| Upside 11%

NIIT Technologies Ltd: Buy| LTP: Rs 1889| Target: Rs 2045| Stop Loss: Rs 1775| Upside 8%

Disclaimer: The views and investment tips expressed by investment experts on are their own and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Kshitij Anand
Kshitij Anand is the Editor Markets at Moneycontrol.